K171751 is an FDA 510(k) clearance for the SmartLinx Vitals Plus NIBP Module, SmartLinx Vitals Plus License for Spot Monitoring Mode, SmartLinx Vitals Plus Alarm Hub, SmartLinx Vitals Plus License for Advanced Monitoring Mode, Covidien FILAC 3000 - Temperature Module. This device is classified as a Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (Class II - Special Controls, product code MWI).
Submitted by Capsule Technologie Sas (Andover, US). The FDA issued a Cleared decision on October 24, 2017, 133 days after receiving the submission on June 13, 2017.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2300.